Transplantation of Isolated Hepatocytes into the Pancreas
作者:
J.P.A.M. Vroemen,
W.A. Buurman,
C.J. van der Linden,
R. Visser,
K.P.M. Heirwegh,
G. Kootstra,
期刊:
European Surgical Research
(Karger Available online 1988)
卷期:
Volume 20,
issue 1
页码: 1-11
ISSN:0014-312X
年代: 1988
DOI:10.1159/000128734
出版商: S. Karger AG
关键词: Hepatocyte transplantation;Acceptor organ;Pancreas;Graft function;assessment;Enzyme deficiency disease
数据来源: Karger
摘要:
In previous research into hepatocyte transplantation (HTX) the spleen was the preferred acceptor organ for isolated donor hepatocytes. In this study the pancreas was tested as an acceptor organ for HTX. HTX into the pancreas or spleen was performed by injection of 107 isolated hepatocytes into the parenchyma of these organs. Intrapancreatic hepatocytes showed good viability 3 months after syngenic HTX as assessed by histological and immunocytochemical parameters. Definite proof of sustained metabolic activity of normal hepatocytes, 3 months after transplantation into the pancreas of congenitally jaundiced rats, was obtained by demonstration of bilirubin conjugates in bile of the recipients: 4.0% of total biliary bilirubin was conjugated. Intrasplenic HTX, however, was more effective and resulted in a conjugated fraction of 17.7% of total biliary bilirubin (p < 0.001). Reduction of total plasma bilirubin was significant with both methods, but more pronounced in intrasplenic HTX. Bile drainage from the hepatocellular transplant via the pancreatic excretory system into the gut was not observed: conjugated bilirubins were not found in pancreatic juice of HTX-treated jaundiced rats. Intrapancreatic HTX did not adversely affect the host rat; evidence of pancreatitis or diabetes was not found. It is concluded that the pancreas is a suitable acceptor organ for HTX. However, intrapancreatic HTX appears to be less effective than intrasplenic HTX in the treatment of enzyme deficiency disease.
点击下载:
PDF
(1708KB)
返 回